Chemical characterization, antioxidant and inhibitory effects of some marine sponges against carbohydrate metabolizing enzymes

Author(s): Shaaban M, Abd-Alla HI, Hassan AZ, Aly HF, Ghani MA


Background: More than 15,000 marine products have been described up to now; Sponges are champion producers, concerning the diversity of products that have been found. Most bioactive compounds from sponges were classified into anti-inflammatory, antitumor, immuno- or neurosurpressive, antiviral, antimalarial, antibiotic, or antifouling. Evaluation of in vitro inhibitory effects of different extracts from four marine sponges versus some antioxidants indices and carbohydrate hydrolyzing enzymes concerned with diabetes mellitus was studied. The chemical characterizations for the extracts of the predominating sponges; SP1 and SP3 were discussed.

Methods: All chemicals served in the biological study were of analytical grade and purchased from Sigma, Merck and Aldrich. All kits were the products of Biosystems (Spain), Sigma Chemical Company (USA), Biodiagnostic (Egypt). Carbohydrate metabolizing enzymes; α-amylase, α-glucosidase, and β-galactosidase (EC3.2.1.1, EC3.2.1.20, and EC3.2.1.23, respectively) were obtained from Sigma Chemical Company (USA).

Results: Four marine sponges; Smenospongia (SP1), Callyspongia (SP2), Niphates (SP3), and Stylissa (SP4), were collected from the Red Sea at Egyptian coasts, and taxonomically characterized. The sponges' extracts exhibited diverse inhibitory effects on oxidative stress indices and carbohydrate hydrolyzing enzymes in linear relationships to some extent with concentration of inhibitors (dose dependant). The extracts of sponges (3, 1, and 2) showed, respectively, potent-reducing power. Purification and Chemical characterization of sponge 1 using NMR and mass spectroscopy, recognized the existence of di-isobutyl phthalate (1), di-n-butyl phthalate (2), linoleic acid (3), β-sitosterol (4), and cholesterol (5). Sponge 3 produced bis-[2-ethyl]-hexyl-phthylester (6) and triglyceride fatty acid ester (7).

Conclusion: Marine sponges are promising sources for delivering of bioactive compounds. Four marine sponges, collected from Red Sea at Egyptian coasts, were identified as Smenospongia (SP1), Callyspongia (SP2), Niphates (SP3), and Stylissa (SP4). The results demonstrated that different sponges extracts exhibited inhibitory effects on oxidative stress indices and carbohydrate hydrolyzing enzymes in linear relationships to some extent with concentration of inhibitors (dose dependant). The extracts of sponges (3, 1, and 2) showed, respectively, potent-reducing power. Chemical characterizations of sponges SP1 and SP3 were discussed. Based on this study, marine sponges are considered as talented sources for production of diverse and multiple biologically active compounds.

Similar Articles

Producing drugs from marine sponges

Author(s): Belarbi el H, Contreras Gómez A, Chisti Y, García Camacho F, Molina Grima E

Marine sponges as pharmacy

Author(s): Sipkema D, Franssen MC, Osinga R, Tramper J, Wijffels RH

Anti-biofilm compounds derived from marine sponges

Author(s): Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, et al.

Biogeography of sponge chemical ecology: comparisons of tropical and temperate defenses

Author(s): Becerro MA, Thacker RW, Turon X, Uriz MJ, Paul VJ

Porifera: Sponges

Author(s): Lavrov D

Drug development from marine natural products

Author(s): Molinski TF, Dalisay DS, Lievens SL, Saludes JP

Marine natural products as anticancer drugs

Author(s): Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH

Approaches to identify, clone, and express symbiont bioactive metabolite genes

Author(s): Hildebrand M, Waggoner LE, Lim GE, Sharp KH, Ridley CP, et al.

The value of natural products to future pharmaceutical discovery

Author(s): Baker DD, Chu M, Oza U, Rajgarhia V

Antiviral lead compounds from marine sponges

Author(s): Sagar S, Kaur M, Minneman KP

Current status on natural products with antitumor activity from Brazilian marine sponges

Author(s): Frota MJ, Silva RB, Mothes B, Henriques AT, Moreira JC

Marine natural products

Author(s): Blunt JW, Copp BR, Keyzers RA, Munro MH, Prinsep MR

Bioactive indole derivatives from the South Pacific marine sponges Rhopaloeides odorabile and Hyrtios sp

Author(s): Longeon A, Copp BR, Quévrain E, Roué M, Kientz B, et al.

Isolation of steroidal glycosides from the Caribbean sponge Pandaros acanthifolium

Author(s): Berrué F, McCulloch MW, Boland P, Hart S, Harper MK, et al.

The odyssey of marine pharmaceuticals: a current pipeline perspective

Author(s): Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, et al.

Monanchocidin: a new apoptosis-inducing polycyclic guanidine alkaloid from the marine sponge Monanchora pulchra

Author(s): Guzii AG, Makarieva TN, Denisenko VA, Dmitrenok PS, Kuzmich AS, et al.

The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis

Author(s): Rothmeier AS, Schneiders UM, Wiedmann RM, Ischenko I, Bruns CJ, et al.

New lysophosphatidylcholines and monoglycerides from the marine sponge Stelletta sp

Author(s): Zhao Q, Mansoor TA, Hong J, Lee CO, Im KS, et al.